On June 01, 2026, PTC Inc (PTC) shares rose 4.6% today, closing at $145.08. This move comes amid a 52-week range that has seen a high of $219.69 and a low of $1
New York, May 29, 2026 (GLOBE NEWSWIRE) -- The Insight Partners published its latest market intelligence report on the Global Digital Twin Market. The study finds the market, valued at US$ 13,739. 99
New York, May 29, 2026 (GLOBE NEWSWIRE) -- The Insight Partners published its latest market intelligence report on the Global Digital Twin Market . The study finds the market, valued at US$ 13,739.99
PTC named Official Engine Design Software Partner of TRD Creo CAD and Windchill PLM are designated solutions for design and development of TRD's high-performance engines Creo CAD and Windchill PLM ena
Mazda selects Codebeamer ALM solution to help strengthen requirements management, improve quality, support compliance, and accelerate innovation for software-defined vehicle development Maintains conn
PTC Inc. (PTC) Presents at J.P. Morgan 54th Annual Global Technology, Media and Communications Conference Transcript
Free access to Onshape, Creo+, Codebeamer+, and a startup package for Arena to manage every stage of the product lifecycle from design and development through compliance and launch Annual renewals ava
Connects Printed Circuit Board (PCB) design from Altium directly into Onshape in a unified cloud-native workflow Eliminates file-based PCB data exchange between electrical and mechanical design Strea
PTC Therapeutics is transitioning from a legacy rare disease business to a growth-focused model, anchored by the successful Sephience launch. Sephience's rapid commercial uptake is offsetting DMD fran

PTC Therapeutics Q1 Earnings Call Highlights

05:08pm, Friday, 08'th May 2026
PTC Therapeutics NASDAQ: PTCT reported a record first quarter for product revenue and raised its 2026 revenue outlook, citing strong early demand for Sephience, its treatment for phenylketonuria, or P
– First quarter 2026 total revenue of $273 million, including $226 million of product revenue, supporting full-year 2026 guidance raise –    – Global Sephience™ (sepiapterin) launch momentu
PTC jumped in pre-market trading after fiscal Q2 2026 revenue rose 22% and AI-driven product demand fueled stronger ARR growth and buybacks.
PTC shares jumped 7.53% in after-hours trading after the company beat Q2 fiscal 2026 revenue estimates by 8.63% and EPS expectations by 33.83%.

PTC Inc. (PTC) Q2 2026 Earnings Call Transcript

09:41pm, Wednesday, 06'th May 2026
PTC Inc. (PTC) Q2 2026 Earnings Call Transcript
While the top- and bottom-line numbers for PTC Inc. (PTC) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare t
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE